The U.S. District Court for the Northern District of Ohio denies the FTC’s bid to prevent company from acquiring its alleged potential competitor (Steris / Synergy Health)

On September 24, 2015, the U.S. District Court for the Northern District of Ohio denied the Federal Trade Commission’s (FTC) bid to enjoin Steris Corporation (Steris) from acquiring its alleged potential competitor, Synergy Health plc (Synergy). The loss breaks a string of victories in merger challenges the FTC has litigated since 2011. Steris and Synergy are the second- and third-largest health care sterilization companies in the world, respectively. In the United States, Steris is one of only two U.S. providers of gamma sterilization services. (Sterigenics International LLC is the other.) Synergy operates more than 36 sterilization facilities outside of the U.S., using both gamma and X-ray sterilization.

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteurs

  • Skadden, Arps, Slate, Meagher & Flom (New York)
  • Skadden, Arps, Slate, Meagher & Flom (New York)
  • Skadden, Arps, Slate, Meagher & Flom (Washington)

Citation

Clifford H. Aronson, Matthew P. Hendrickson, John H. Lyons, The U.S. District Court for the Northern District of Ohio denies the FTC’s bid to prevent company from acquiring its alleged potential competitor (Steris / Synergy Health), 24 septembre 2015, e-Competitions September 2015, Art. N° 75798

Visites 188

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues